期刊文献+

我院产科门诊超说明书用药合理性分析

Rationality Analysis of Off-label Drug Use in Obstetric Outpatient Department in one Hospital
下载PDF
导出
摘要 目的为保证临床合理用药,对我院产科门诊超说明书用药进行调查分析。方法通过医院信息系统抽取我院产科2021年1月~2021年6月门诊处方共5042张,根据药品说明书内容,对其中超说明书用药进行统计,并依据循证医学证据进行超说明书用药合理性分析。结果5042张处方中超说明书用药113张,包括9种药品,超说明书用药比例为2.24%,其中以超适应证用药为主,共83张。结论我院产科超说明书用药有一定的证据支持,但仍需规范超说明书用药管理,加强医患沟通,保证用药安全。 OBJECTIVE To investigate and analyze off-label drug use in obstetric outpatient department in our hospital in order to ensure rational clinical drug use.METHODS A total of 5042 outpatient prescriptions were extracted from the department of obstetrics in our hospital from January 2021 to June 2021 through the hospital information system,According to the contents of drug instructions,the off-label drug use was statistically analyzed,and the rationality of off-label drug use was analyzed based on evidence-based medical evidence.RESULTS Among 5042 prescriptions,113 drugs,including 9 drugs,were used off-label,the proportion of off-label drug use was 2.24%,83 drugs were mainly used off-label.CONCLUSION There is some evidence to support off-label drug use in obstetrics department in our hospital,but it is still necessary to standardize the management of off-label drug use,strengthen doctor-patient communication,and ensure drug safety.
作者 曾茜 ZENG Qian(Department of Clinical Pharmacy,Nanping First Hospital,Nanping 353000,China)
出处 《海峡药学》 2022年第4期146-149,共4页 Strait Pharmaceutical Journal
关键词 超说明书用药 产科 医患沟通 用药安全 Off-label drug use Obstetric Doctor-patient communication Medication safety
  • 相关文献

参考文献22

二级参考文献332

  • 1李晓茵,陈文姗,钟树林,陈凤云,萧丽娟.米非司酮与米索前列醇、戊酸雌二醇治疗稽留流产疗效比较[J].广州医科大学学报,2019,0(5):93-95. 被引量:10
  • 2余艳红,沈立勇,钟梅,张宇,苏桂栋,高云飞,全松,曾莉.肝素治疗胎儿生长受限的临床观察[J].中华妇产科杂志,2004,39(12):793-796. 被引量:44
  • 3杜乃立,戚文航.外周多巴胺受体激动剂及其应用[J].国外医学(心血管疾病分册),2000,27(3):131-133. 被引量:7
  • 4Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus workshop group. Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome(PCOS)[J]. Hum Reprod,2004,19( 1 ) :41-47.
  • 5Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus workshop group. Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004,81 ( 1 ) : 19-25.
  • 6Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome[J]. Fertil Steril, 2008,89(3 ) : 505-522.
  • 7Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome[J]. Hum Reprod, 2008,23 (3) : 462-477.
  • 8Blank SK,Helm KD,McCartney CR,et al. Polycystic ovary syndrome in adolescence[J]. Ann N Y Acad Sei, 2008,1135:76-84.
  • 9Apter D. Endocrine and metaholic abnormalities in adolescents with a PCOS-like condition: consequences for aduh reproduction [J]. Trends Endocrinol Metal), 1998,9(2) :58-61.
  • 10van Hooff MH, Voorhorst FJ, Kaptein MB,et al. Predictive value of menstrual cycle pattern, body mass index,hormone levels and polycystie ovaries at age 15 years for oligo-amenorrhoea at age 18 years[J]. Hum Reprod, 2004, 19 ( 2 ) : 383-392.

共引文献2221

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部